Multidisciplinary Evaluation denied for failing step therapy by Humana?

Humana's specific coverage criteria for multidisciplinary evaluation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Uses Step Therapy for Multidisciplinary Evaluations — and How to Challenge It

Applying a step-therapy ("fail first") protocol to a multidisciplinary evaluation is unusual and, in many clinical contexts, inappropriate. Step therapy is typically used for drug coverage — requiring a patient to try a lower-cost medication before a more expensive one is covered. When applied to a professional evaluation service, it usually means Humana is requiring documentation that the patient first received care through simpler or less resource-intensive pathways before a coordinated specialist review will be authorized. When those prior steps have already occurred — or when the patient's condition makes sequential care inadequate — this requirement can be directly contested.

## The Federal Appeal Framework

• Internal appeal (Level 1): Submit a written appeal within Humana's deadline (typically 180 days from the denial for non-urgent cases). Pre-service decisions require a response within 30 days; urgent requests within 72 hours.
• Step-therapy override: Many states have enacted step-therapy override laws that require insurers to waive the step requirement when: (a) the required prior steps were already tried and failed, (b) the required prior steps are contraindicated or likely to cause harm, or (c) the patient is clinically stable on the requested treatment. Check whether your state has enacted such a law.
• External review (ACA §2719): After exhausting internal appeals, request independent external review — generally within 4 months of a final adverse determination. The IRO will assess whether the step-therapy protocol was appropriately applied.
• ERISA §503: For employer-sponsored plans, the denial must provide specific clinical reasoning; a generic step-therapy citation without patient-specific analysis is inadequate.

## Documents to Gather

1. Prior care history: A chronological record of all treatments, consultations, and evaluations the patient has already undergone — with dates, outcomes, and reasons for discontinuation or inadequacy. This is the most important document for overcoming a step-therapy denial. 2. Documentation of failed or insufficient prior steps: For each step Humana claims was not completed, either (a) show it was completed with specific results, or (b) have the physician explain why that step was clinically inappropriate or contraindicated for this patient. 3. Coordinating physician letter: A letter explaining why proceeding through additional sequential steps would cause clinical harm, delay necessary treatment, or be otherwise medically inappropriate for this patient's specific condition and timeline. 4. Guideline reference: Ask your physician to cite the applicable specialty organization's recommendation for when multidisciplinary evaluation — rather than sequential referrals — is the standard of care. 5. State law research: If your state has a step-therapy override statute, include a brief citation to that law and explain how your situation meets the override criteria.

## Criteria-Mapping Structure

Address the step-therapy protocol requirement by requirement. For each step Humana lists:

• If completed: provide the date, treating provider, and documented outcome.
• If not completed: provide your physician's written explanation of why that step was skipped and the clinical basis for doing so.

End the letter with a clear statement that all required steps have been satisfied or that waiver is warranted, and that further delay of the multidisciplinary evaluation will cause harm by postponing coordinated care that is already medically indicated.